The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Financial institutions Piper Sandler and RBC Capital Markets have lowered their price targets for Becton, Dickinson and Company (BDX) to $159 and $175 respectively, citing revised Q2 revenue growth assumptions and headwinds from the Alaris product line. Adding to the cautious sentiment, Executive Vice President Michael Feld recently sold 74 shares of his holdings in the company. This transaction aligns with a broader trend, as BDX has recorded 17 insider sells versus only one insider buy over the past year. Analysts noted that the stock is likely to remain range-bound due to a lack of clear catalysts. While some metrics suggest the stock may be undervalued, the combination of downward price target revisions and consistent insider divestment signals near-term valuation pressure. The collective outlook remains cautious despite maintained neutral ratings.
Sign in to access this content
Sign In